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Background: Dopamine signaling is mediated by Gs protein-coupled “D1-like” receptors (D1 and D5) and Gi-
coupled “D2-like” receptors (D2-4). In asthmatic patients, inhaled dopamine induces bronchodilation. Although the
Gi-coupled dopamine D2 receptor is expressed and sensitizes adenylyl cyclase activity in airway smooth muscle
(ASM) cells, the Gs-coupled dopamine D1-like receptor subtypes have never been identified on these cells.
Activation of Gs-coupled receptors stimulates cyclic AMP (cAMP) production through the stimulation of adenylyl
cyclase, which promotes ASM relaxation. We questioned whether the dopamine D1-like receptor is expressed on
ASM, and modulates its function through Gs-coupling.
Methods: The mRNA and protein expression of dopamine D1-like receptor subtypes in both native human and
guinea pig ASM tissue and cultured human ASM (HASM) cells was measured. To characterize the stimulation of
cAMP through the dopamine D1 receptor, HASM cells were treated with dopamine or the dopamine D1-like
receptor agonists (A68930 or SKF38393) before cAMP measurements. To evaluate whether the activation of
dopamine D1 receptor induces ASM relaxation, guinea pig tracheal rings suspended under isometric tension in
organ baths were treated with cumulatively increasing concentrations of dopamine or A68930, following an
acetylcholine-induced contraction with or without the cAMP-dependent protein kinase (PKA) inhibitor Rp-cAMPS,
the large-conductance calcium-activated potassium (BKCa) channel blocker iberiotoxin, or the exchange proteins
directly activated by cAMP (Epac) antagonist NSC45576.
Results: Messenger RNA encoding the dopamine D1 and D5 receptors were detected in native human ASM tissue
and cultured HASM cells. Immunoblots confirmed the protein expression of the dopamine D1 receptor in both
native human and guinea pig ASM tissue and cultured HASM cells. The dopamine D1 receptor was also
immunohistochemically localized to both human and guinea pig ASM. The dopamine D1-like receptor agonists
stimulated cAMP production in HASM cells, which was reversed by the selective dopamine D1-like receptor
antagonists SCH23390 or SCH39166. A68930 relaxed acetylcholine-contracted guinea pig tracheal rings, which was
attenuated by Rp-cAMPS but not by iberiotoxin or NSC45576.
Conclusions: These results demonstrate that the dopamine D1 receptors are expressed on ASM and regulate
smooth muscle force via cAMP activation of PKA, and offer a novel target for therapeutic relaxation of ASM.
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Dopamine is a ubiquitous endogenous catecholamine
neurotransmitter in the mammalian central nervous sys-
tem, where it controls a variety of physiological responses
including emotion, cognition, and endocrine functions
[1-3]. This catecholamine also modulates cardiovascular
function, hormone secretion, vascular tone, renal function,
and gastrointestinal motility through the specific dopa-
mine receptor subtypes expressed in peripheral organs
and tissues [3-7]. The dopamine receptor is a member of
the large family of 7 transmembrane spanning domain G
protein-coupled receptors (GPCRs). The five known sub-
types of dopamine receptors have been subdivided into
two distinct subclasses, “D1-like” receptors (D1 and D5)
which couple to the Gs protein and “D2-like” receptors
(D2, D3 and D4) which couple to Gi [3,8].
Inhaled dopamine induces bronchodilation during
bronchial obstruction in asthmatic patients [9-11]. The
dopamine-induced bronchodilation has been thought to
be mediated via β2-adrenoceptors because this effect is
partially blocked by the β-adrenoceptor antagonist pro-
pranolol [12]. However, a recent study suggested that
the dopamine D1-like receptor antagonist SCH23390
inhibited the bronchodilator effect of dopamine in
acetylcholine-contracted rat tracheal rings suspended in
organ baths [13], suggesting that the dopamine D1-like
receptor is expressed on airway smooth muscle and in-
duces bronchodilation. Although chronic activation of
the dopamine D2 receptor has been shown to sensitize
adenylyl cyclase and facilitate forskolin-induced airway
smooth muscle relaxation [14], the functional expression
of the dopamine D1-like receptor subtype on airway
smooth muscle has not been described.
Activation of Gs-coupled receptors leads to stimulation
of adenylyl cyclase activity resulting in an increase in cellu-
lar cyclic AMP (cAMP) levels. Increase in intracellular
cAMP levels activates cAMP-dependent protein kinase
(PKA). PKA has many intracellular targets including the
phosphorylation of myosin light chain kinase (MLCK),
which classically promotes airway smooth muscle relax-
ation [15,16]. In addition, exchange proteins directly acti-
vated by cAMP (Epac) have recently been identified on
airway smooth muscle as novel cAMP sensors able to
elicit airway smooth muscle relaxation in human and
guinea pig [17,18]. These findings led us to hypothesize
that functional dopamine D1-like receptors could respond
to dopamine in airway smooth muscle and promote its re-
laxation through cellular cAMP’s activation of multiple
potential signaling pathways.
In the present study, the expression of the dopamine
D1-like receptor was assessed in native human and
guinea pig airway smooth muscle tissue and cultured
human airway smooth muscle (HASM) cells. In addition,
cAMP production and dopamine D1 receptor effects onex vivo contractile tone were assessed to confirm its
physiological role in airway smooth muscle.
Materials and methods
Materials
M-199 smooth muscle medium, human fibroblast growth
factor, human epidermal growth factor, fetal bovine serum
(FBS), and antibiotic-antimycotic were purchased from
Life Technologies (Grand Island, NY). Lysates of human
brain cerebral cortex and kidney used as positive protein
controls on immunoblots were obtained from BD Biosci-
ences (Palo Alto, CA). Protease inhibitor cocktail III was
purchased from EMD Biosciences (San Diego, CA).
A68930 and SCH39166 were purchased from Tocris Bio-
science (Ellisville, MO). NSC45576 was a kind gift from
the Open Clinical Repository of the National Cancer Insti-
tute’s Developmental Therapeutics Program. HitHunter™
cAMP XS+ assay kit was purchased from DiscoveRx
(Fremont, CA). All other chemicals were obtained from
Sigma (St. Louis, MO) unless otherwise stated.
Cell culture
Cultures of HASM cells came from three sources. Primary
cultured HASM cells were obtained from (1) Lonza
(Walkersville, MD), and (2) were a kind gift from Dr.
Reynold A Panettieri, Jr. (University of Pennsylvania, PA),
which were obtained from lung transplant donors in ac-
cordance with procedures approved by the University of
Pennsylvania Committee on Studies Involving Human Be-
ings as previously described [19]. (3) Cultures of immor-
talized HASM cells were a kind gift from Dr. William
Gerthoffer (University of South Alabama, Mobile, AL) and
have previously been characterized [20]. Cells were grown
in culture medium M-199, supplemented with 10% FBS,
1 ng/ml human fibroblast growth factor, 250 pg/ml human
epidermal growth factor, and an antibiotic-antimycotic
mix (100 units/ml penicillin G sodium, 100 μg/ml strepto-
mycin sulfate, 0.25 μg/ml amphotericin B) at 37°C in 95%
air/5% CO2.
Isolation of smooth muscle from human and guinea pig
trachea
All Studies were approved by Columbia University’s In-
stitutional Review Board (IRB) and deemed not human
subjects research under 45 CFR 46. Human trachea was
obtained from discarded regions of healthy donor lungs
harvested for lung transplantation at Columbia Univer-
sity. Human tissue was transported in cold buffer as de-
scribed [14].
All guinea pig studies were approved by the Columbia
University Institutional Animal Care and Use Commit-
tee. These studies were also reviewed by the Committee
on the Ethics of Animal Experiments in Tohoku Univer-
sity School of Medicine, and they were carried out in
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ments issued by the Tohoku University and The Law
(No. 105) and Notification (No. 6) issued by the Japanese
Government. Adult male Hartley guinea pigs (approx.
400 g body weight) were deeply anesthetized by intraper-
itoneal pentobarbital (50 mg/kg). The chest cavity was
opened, and the guinea pigs were exsanguinated. The
entire trachea and whole brain (positive control for im-
munoblot) were surgically removed and immersed in
cold (4°C) KH buffer. The exteriors of either the human
or guinea pig trachea were carefully dissected free of ad-
herent connective tissue under a microscope. Epithelium
was left intact for immunohistochemistry but removed
for organ bath experiments and immunoblotting.
Isolation of RNA and reverse transcriptase polymerase
chain reaction
Total RNA was extracted from freshly dissected native
human airway smooth muscle, and primary cultured
HASM cells (Lonza, Walkersville, MD) using TRIzol Re-
agent (Ambion, Austin, TX) according to the manufac-
turer’s recommendations. Total RNA from whole human
brain (Clontech, Mountain View, CA) was used as a
positive control. The extracted RNA from freshly dis-
sected native human airway smooth muscle and primary
cultured HASM cells were treated enzymatically with
DNase I (Life Technologies, Grand Island, NY) to digest
contaminating genomic DNA according to the manufac-
turer’s instructions. cDNA was synthesized using Super-
Script VILO cDNA Synthesis Kit (Life Technologies,
Grand Island, NY). Briefly, 1 μg of DNase I-treated total
RNA was reverse transcribed at 42°C. The reaction was
terminated by heating to 85°C for 5 min and then cooled
at 4°C.
PCR was performed and analyzed as described (1) with
sense and antisense primers corresponding to the “D1
subgroup (D1 and D5) of dopamine receptors (Table 1).
Two-step PCR (annealing and extension at same
temperature) was performed with Mastercycler ep gradi-
ent S thermal cycler (Eppendorf, Hamburg, Germany)
for all PCR reactions and all reactions included an initial
denaturation step at 94°C for 1 min followed by 40 cycles
of denaturation (94°C for 10 s) and annealing/extension
at 72°C for 1 min. Dopamine D1 primers were designedTable 1 primer sequences for dopamine D1-like receptor subt
Target Sequence of primer
(GenBank access no.)
Human Dopamine D1 FP: 5′-CCA GCG AAG TC
(NM_000794) RP: 5′-GCC TCT GCT CTG
Human Dopamine D5 FP: 5′- CTG GTG TGC GC
(NM_000798) RP: 5′- ACC CAG ACG T
FP forward primer, RP reverse primer.to anneal in two separate exons spanning a large intron to
ensure that amplified PCR products resulted from amplified
cDNA and not contaminating genomic DNA. Since the
dopamine D5 receptor gene is intronless, complete removal
of genomic DNA from the RNA samples was verified by
performing negative control reactions in which reverse
transcriptase was omitted from the cDNA synthesis reac-
tion (-RT controls). PCR products were electrophoresed on
5% nondenaturing polyacrylamide gel in Tris, acetate,
EDTA buffer. The gel was stained with ethidium bromide,
and visualized using ultraviolet illumination. The gel image
was captured with a model Powershot A570 digital camera
(Canon, Tokyo, Japan).
Immunoblot analysis
Confluent cultures of HASM cells were rinsed with cold
phosphate-buffered saline (PBS), and mechanically scraped
from the surface of the T75 culture flask in the presence of
protease inhibitor cocktail III. Cells were pelleted (500 g,
10 min, 4°C) and lysed in cold lysis buffer [50 mM Tris–
HCl, pH 8.0, 1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS, 150 mM NaCl, 1 mM EDTA, 1:200 dilution of
protease inhibitor cocktail III, 1 mM Na3VO4, 1 mM NaF].
Lysed cells were centrifuged (15,000 g, 15 min, 4°C) and an
aliquot of the supernatant was subjected to protein analysis
and storing at -80°C. Freshly dissected native human and
guinea pig airway smooth muscle, and guinea pig brain
cerebral cortex was homogenized (Tekmar Ultra Turrax
T25 high-speed homogenizer set at top speed for 30 s) in
cold (4°C) buffer (50 mM Tris, 10 mM HEPES, pH 7.4,
1 mM EDTA with a 1:200 dilution of protease inhibitor
cocktail III). The homogenate was filtered through 125-μm
Nitex mesh and centrifuged twice at 500 g for 15 min. The
supernatant was transferred into new tubes and
centrifuged at 50,000 g for 30 min at 4°C. The final mem-
brane pellet was resuspended in the same buffer for protein
concentration determinations and stored at -80°C. Each
sample was solubilized by heating at 95°C for 10 min in
sample buffer before use.
All the samples and positive controls were elec-
trophoresed (8% SDS-PAGE) and transferred to PVDF
membranes. 5% membrane blocking agent (GE Healthcare,
RPN2125V, Waukesha, WI) in Tris-buffered saline with
0.1% Tween 20 (TBST) was used to block non-specificypes
Amplicon
size (bp)
C ACA TTC CAA GCT CC-3′ 207
CTA GTC AGT TGC AAT CAC-3′
A GCC ATC GT-3′ 173
CG CAG AAC GC-3′
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then probed with antibodies directed against the dopamine
D1 receptor protein (rabbit monoclonal 1:1,000; Epitomics,
2192-1, Burlingame, CA) or the dopamine D5 receptor pro-
tein (rabbit polyclonal 1:500; Santa Cruz, sc-25650, Santa
Cruz, CA) overnight at 4°C. After washing three times with
TBST, membranes were incubated for 1 hr at room
temperature with HRP-labeled secondary anti-rabbit anti-
bodies (1:5,000; GE Healthcare, NA934V, Waukesha, WI).
The signals from the immunoreactive bands were detected
by ECL Plus (GE Healthcare, Waukesha, WI) and were
captured using chemiluminescent image analyzer (LAS
4000 Mini; GE Healthcare, Waukesha, WI).
Immunohistochemistry
Human and guinea pig tracheal rings were fixed, paraffin
embedded, sectioned and rehydrated as previously de-
scribed [14]. Heat-mediated antigen retrieval, blockade of
endogenous peroxidase, protein blocking and avidin-biotin
blocking was performed as described [14] and slides were
incubated overnight at 4°C in primary antibody against the
dopamine D1 receptor protein (rabbit monoclonal 1:2,000;
Epitomics, 2192-1, Burlingame, CA) or dopamine D5 re-
ceptor protein (rabbit polyclonal 1:2,000; Santa Cruz, sc-
25650, Santa Cruz, CA), in 2% normal goat serum in PBS
with 0.1% Triton X-100 (PBST). A parallel tracheal ring
section was incubated with an isotype-specific rabbit IgG
antibody as a negative control. After overnight incubation
at 4°C, slides were washed three times with PBST and pri-
mary antibodies were detected using biotinylated anti-
rabbit antibodies (Vector Laboratories, Peterborough, UK)
at a concentration of 1:100. After incubation with ABC-
HRP complex (Vector Laboratories, Peterborough, UK)
for 30 min, the antigen antibody complex was then visua-
lized with the peroxidase substrate kit (DAB) (SK-4100,
Vector Laboratories, Peterborough, UK). Sections were
counterstained with hematoxylin (Vector Laboratories,
Peterborough, UK), dried, dehydrated in a graded alcohol
series and xylene, and cover slipped using Poly-mount
(Polysciences, Warrington, PA).cAMP assays
The dopamine D1 receptor-mediated cAMP production
in primary cultured HASM cells (Lonza; Walkersville,
MD) was measured using a HitHunter™ cAMP XS+
Assay kit according to the manufacturer’s instructions.
Briefly, HASM cells in white 96-well plates were washed
twice with warm PBS (37°C). The cells were incubated
with dopamine (1 μM), or the dopamine D1-like recep-
tor agonists (A68930 or SKF38393) (1 μM) for 20 min at
37°C. To examine the effect of dopamine on cAMP pro-
duction in the presence of dopamine D2 receptor block-
ade, the cells were pretreated with the dopamine D2receptor antagonist L-741626 (1 μM) for 30 min
followed by incubation with dopamine (1 μM) for 20 min
at 37°C. Incubation of the cells with L-741626 (1 μM)
alone was also performed to determine whether L-741626
by itself exerts any effect on cAMP production. To exam-
ine the dose-dependent and time-course effects of the
dopamine D1-like receptor agonist A68930 on cAMP pro-
duction, the cells were incubated with A68930 (1 nM -
100 μM) for 10 - 60 min at 37°C. In separate experiments,
the cells were pretreated with the dopamine D1-like recep-
tor antagonists [SCH23390 (1 μM) or SCH39166 (1 μM)]
or vehicle (PBS) for 30 min followed by incubation with
A68930 (1 μM) for 20 min at 37°C. Then cAMP XS anti-
body reagent followed by the mixture of enzyme donor
(ED)/Lysis/chemiluminescence (CL) working solution was
added to each well. After incubation for 60 min at room
temperature, cells were further incubated with the enzyme
acceptor (EA) reagent for 3 hrs at room temperature. Lu-
minescence signals were detected using a multimode
microplate reader (Appliskan, Thermo Fisher Scientific,
Waltham, MA).In vitro assessment of dopamine D1 receptor agonist
effect on guinea pig airway smooth muscle relaxation
after contraction with acetylcholine
Guinea pig tracheas were dissected and equilibrated in
organ baths as described [21]. All rings were precontracted
with 10 μM N-vanillylnonanamide (capsaicin analogue)
and then 2 cycles of cumulatively increasing concentrations
of acetylcholine (0.1 μM - 1 mM) with extensive buffer
washes and resetting of the resting tension to 1.0 g be-
tween cycles. Rings were pretreated with 1 μM tetrodo-
toxin and 10 μM pyriliamine to eliminate the confounding
effects of neural depolarizations and histamine release, re-
spectively. Rings were then contracted with acetylcholine
(an individual EC50 or EC75 calculated for each ring). Fol-
lowing the achievement of a stable contraction (typically
15 min), cumulatively increasing concentrations of dopa-
mine (1 μM – 100 μM), the dopamine D1-like receptor
agonist A68930 (1 μM - 100 μM) or the β-
adrenoceptor agonist isoproterenol (0.5 nM – 1 μM)
was incrementally added to the buffer in the baths.
Control-contracted rings received vehicle (KH buffer) to
serve as time controls for the A68930-induced relaxation.
In separate experiments, rings were pretreated for 15 min
with the dopamine D2 receptor selective antagonist L-
741626 (10 μM), PKA inhibitor Rp-cAMPS (100 μM),
large-conductance calcium-activated potassium (BKCa)
channel blocker iberiotoxin (100 nM) or the Epac an-
tagonist NSC45576 (250 μM) before the addition of
cumulatively increasing concentrations of A68930
(1 μM – 100 μM) or isoproterenol (0.5 nM – 1 μM) to
assess their effects on airway smooth muscle force.
Figure 1 RT-PCR analysis of dopamine D1-like receptors in
human airway smooth muscle. Representative gel images of RT-
PCR analysis of total RNA using primers specific for human
dopamine D1 receptor (A) and D5 receptor (B). Total RNA extracted
from freshly dissected human tracheal airway smooth muscle or
primary cultures of human airway smooth muscle (HASM) cells was
analyzed. Lanes 1: base pair standards; Lanes 2: negative control (no
RNA); Lanes 3: total RNA from freshly dissected native human airway
smooth muscle tissue; Lanes 4: total RNA from primary cultured
HASM cells obtained from Lonza (Walkersville, MD); Lanes 5: total
RNA from whole human brain. −RT; cDNA synthesis reactions
performed in the absence of reverse transcriptase confirming that
PCR products were not arising from contaminating genomic DNA.
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Statistical analysis was performed using repeated mea-
sures of ANOVA, followed by Bonferroni posttest com-
parison using GraphPad Instat 3.0.6 software (GraphPad
Software Inc., San Diego, CA). Data are presented as
mean ± SEM; P < 0.05 was considered significant.
Results
RT-PCR analysis of dopamine D1-like receptors in human
airway smooth muscle
RT-PCR analysis demonstrated the expression of mRNA en-
coding dopamine D1-like receptors (D1 and D5) in both
freshly dissected native human airway smooth muscle tissue
from the upper airways and in primary cultures of HASM
cells from Lonza (Walkersville, MD) (Figure 1). The set of
primers to amplify the cDNA of the “D1 subgroup (D1 and
D5) of dopamine receptors are shown in Table 1. Total
RNA from whole human brain (Clontech, Mountain View,
CA) was used as a positive control. When cDNA was pre-
pared in the absence of reverse transcriptase (-RT controls),
no dopamine D5 receptor PCR products were obtained
confirming that PCR products were arising from cDNA and
not from contaminating genomic DNA (Figure 1B, right).
Immunoblot analysis of dopamine D1-like receptors in
human and guinea pig airway smooth muscle
A single immunoreactive band of expected molecular
mass of approximately 75 kDa for dopamine D1 receptor
was identified in freshly dissected native human airway
smooth muscle, cultured HASM cells from all three differ-
ent sources [#1: cultures of immortalized HASM cells
gifted from Dr. William Gerthoffer, #2: primary cultured
cells gifted from Dr. Reynold A Panettieri, Jr., and #3: pri-
mary cultured cells obtained from Lonza (Walkersville,
MD)], and in human whole kidney (positive control)
(Figure 2A). In contrast, no immunoreactive bands of ap-
propriate molecular mass of approximately 53 kDa for
dopamine D5 receptor was identified airway smooth
muscle in freshly dissected native human and guinea pig
airway smooth muscle tissue and cultured HASM cells ex-
cept in whole brain extracted from human and guinea pig
which were used as a positive control (Figure 2B).
Immunohistochemical detection of dopamine D1 receptor
expression in human and guinea pig airway smooth muscle
To confirm the localization of dopamine D1 and D5 recep-
tor protein in airway smooth muscle, immunohistochem-
istry was performed using a rabbit monoclonal antibody
that recognizes the dopamine D1 receptor protein and a
rabbit polyclonal antibody that recognizes the dopamine
D5 receptor protein in paraffin sections of both human
and guinea pig tracheal rings. Specific immunohistochemi-
cal staining of the dopamine D1 receptor was obtained
throughout the smooth muscle layer of both human andguinea pig trachea (indicated by brown color) (Figure 3A
and 3E). Consecutive sections processed with the isotype-
specific rabbit IgG negative control primary antibody pro-
duced no staining (Figure 3B and 3F). In contrast, no
staining of dopamine D5 receptor was obtained in the
smooth muscle layer (Figure 3C and 3G), and consecutive
sections processed with the isotype-specific rabbit IgG
negative control primary antibody produced no staining
(Figure 3D and 3H).
Dopamine D1 receptor agonist-induced cAMP activity in
human airway smooth muscle cells
Dopamine D1 receptor-mediated production of cAMP is
well known in neurons. To examine whether dopamine
Figure 2 Immunoblot analysis of dopamine D1-like receptors in
human and guinea pig airway smooth muscle. Representative
immunoblot analyses using antibodies against the dopamine D1
receptor (A) and D5 receptor (B) using 100 μg total protein
prepared from freshly dissected native human tracheal airway
smooth muscle (SM), cultured HASM cells from all three different
sources [#1: cultures of immortalized HASM cells gifted from Dr.
William Gerthoffer, #2: primary cultured cells gifted from Dr. Reynold
A. Panettieri, Jr., and #3: primary cultured cells obtained from Lonza
(Walkersville, MD)], freshly dissected native guinea pig tracheal SM,
human kidney, and human or guinea pig brain cerebral cortex.
White spaces between the lanes in (B) indicate that these lanes
were located on the same immunoblot but were not located in
neighboring lanes on the original gel and immunoblot image.
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tured HASM cells, we measured cAMP activity in the
presence or absence of dopamine (1 μM) or the dopamine
D1 receptor agonists (A68930 or SKF38393) (1 μM). Both
dopamine D1-like receptor agonists significantly stimulated
cAMP synthesis (A68930; P < 0.001, n = 25; SKF38393; P <
0.05, n = 14), while dopamine did not exert any effect (n.s.,
n = 12) (Figure 4A). However, when the cells were
pretreated with the dopamine D2 receptor antagonist L-
741626 (1 μM) for 30 min, dopamine (1 μM) significantly
stimulated cAMP synthesis (P < 0.01, n = 4), while L-
741626 by itself did not exert any effect (Figure 4B). The
dopamine D1-like receptor agonist A68930 significantly
stimulated cAMP synthesis at concentrations ranging
from 0.1 to 10 μM (P < 0.001 at 1 μM A68930, n = 13)
(Figure 4C). A68930 (1 μM)-induced cAMP production
peaked at 20 min and then slowly declined (Figure 4D).
From these data, we chose the concentration of 1 μM
A68930 and a duration of treatment of 20 min in the fol-
lowing experiments. A68930 (1 μM)-induced cAMP pro-
duction was significantly blocked by pretreatment with the
dopamine D1 receptor antagonists SCH23390 (1 μM) (P <0.01, n = 9) or SCH39166 (1 μM) (P < 0.01, n = 7)
(Figure 4E).
Dopamine D1 receptor agonist induced airway smooth
muscle relaxation after an acetylcholine EC50 contraction
in intact guinea pig trachea
Molecular identification of the dopamine D1 receptor,
which stimulates cAMP production on airway smooth
muscle, led us to question whether the receptor expressed
on airway smooth muscle could modulate airway smooth
muscle tone. Guinea pig tracheal rings contracted with an
EC50 concentration of acetylcholine were significantly re-
laxed by dopamine (P < 0.05 compared with time control
at 20 μM dopamine, and P < 0.01 compared with time con-
trol at 50 - 100 μM dopamine, n = 5) (Figure 5) and the
dopamine D1-like receptor agonist A68930 (P < 0.01 com-
pared with time control at 20 - 100 μM A68930, n = 6)
(Figure 6). When guinea pig tracheal rings were contracted
with higher concentrations of acetylcholine (EC75), A68930
(100 μM) still relaxed tracheal rings to the similar degree
(n = 7) compared with its relaxation after contraction with
an EC50 concentration of acetylcholine (n = 9) (34.83 ±
11.37% vs. 38.83 ± 12.35% of initial tension from acetylcho-
line EC75 and EC50 contraction, respectively, n.s.) (data not
shown in figures). Although A68930 is a potent highly se-
lective dopamine D1 receptor agonist (EC50 = 2.1 nM), it
also acts as an weaker agonist on the dopamine D2 recep-
tor at higher concentration (EC50 = 3.92 μM) [22]. To con-
firm A68930-induced airway relaxation is not mediated via
dopamine D2 receptor, we used the dopamine D2 receptor
selective antagonist L-741626. Interestingly, under identical
conditions, the pretreatment of rings with L-741626
(10 μM) significantly augmented the airway relaxation in-
duced by A68930 (P < 0.05 compared with A68930 alone
at 50 - 100 μM A68930, n = 6) (Figure 6).
Protein kinase A (PKA) is involved in Dopamine D1
receptor agonist-induced guinea pig airway smooth
muscle relaxation
Classically, activation of PKA by cAMP facilitates airway
smooth muscle relaxation [23]. To examine the role of PKA
in regulating dopamine D1 receptor-mediated airway
smooth muscle relaxation, we used Rp-cAMPS as a PKA in-
hibitor. The pretreatment of guinea pig airway rings with
Rp-cAMPS (100 μM) significantly attenuated the relaxation
induced by A68930 (P < 0.01 compared with A68930 alone,
n = 6) (Figure 7). In contrast, blockade of the BKCa channel
with iberiotoxin did not inhibit the relaxation induced by
A68930 (n.s. compared with A68930 alone, n = 6) (Figure 7).
Dopamine D1 receptor-mediated guinea pig airway
relaxation is Epac independent
Recently, Epac has been recognized as an alternative cAMP
effector able to elicit airway smooth muscle relaxation [17].
Figure 3 Immunohistochemical detection of dopamine D1 receptor expression in human and guinea pig airway smooth muscle.
(A and C) Representative immunohistochemical staining of dopamine D1 receptor (A), and dopamine D5 receptor (C) in paraformaldehyde/
glutaraldehyde-fixed human trachea. (B and D) Anti-rabbit IgG isotype negative control in serial section of human tracheal airway smooth
muscle. (E and G) Representative immunohistochemical staining of dopamine D1 receptor (E), and dopamine D5 receptor (G) in
paraformaldehyde-fixed guinea pig trachea. (F and H) Anti-rabbit IgG isotype negative control in serial section of guinea pig trachea. All sections
were counterstained with hematoxylin. Calibration bar: 100 μm. ASM, airway smooth muscle; Epi, airway epithelium. Images are representative of
at least 3 independent immunohistochemical analyses from human and guinea pig trachea.
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receptor-meidated airway relaxation, Epac antagonist
NSC45576 was used. The pretreatment of guinea pig
airway rings with NSC45576 (250 μM) did not block
A68930-induced airway relaxation (n.s. compared with
A68930 alone, n = 4) (Figure 8A and 8B). Isoproterenol,which is considered to exert airway smooth muscle re-
laxation in part through Epac [17], was used to confirm
that NSC45576 was effective as an Epac antagonist in
guinea pig airway smooth muscle. NSC45576 resulted
in a significant rightward shift in the isoproterenol re-
laxation concentration-response curve compared with
Figure 4 Dopamine D1 receptor agonist-induced cAMP activity in human airway smooth muscle cells. (A) The effects of dopamine (DA;
1 μM) or the dopamine D1-like receptor agonists (A68930 or SKF38393; 1 μM respectively) on cAMP production in cultured HASM cells. Number
of experiments was shown in parentheses. (B) The effects of dopamine (1 μM) on cAMP production in the presence or absence of the dopamine
D2 receptor antagonist (L-741626; 1 μM for 30 min pretreatment before dopamine treatment). N = 4. (C) Concentration-dependent effect of
dopamine D1-like receptor agonist A68930 (1 nM - 100 μM) on cAMP production in cultured HASM cells. The cells were incubated with A68930
for 20 min before cAMP assay. N = 4 - 13. (D) Time-course effect of A68930 (1 μM) on cAMP production in cultured human airway smooth
muscle cells. N = 6. (E) The effect of dopamine D1-like receptor selective antagonists SCH23390 or SCH39166 on A68930-stimulated cAMP
production in HASM cells. Cells were pretreated with SCH23390 (1 μM) or SCH39166 (1 μM) for 30 min pretreatment prior to A68930 (1 μM)
treatment for 20 min. Data represent means ± SEM. N = 7 - 9. *P < 0.05, **P < 0.01 and ***P < 0.001 compared with basal. ##P < 0.01 compared with
A68930 alone. In each experiment, values were determined in triplicate.
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5.2 nM, respectively; P < 0.05 at 10 nM isoproterenol,
n = 5] (Figure 8C and 8D).
Discussion
The major finding of the present study is that functional
dopamine D1 receptors are expressed in both human and
guinea pig airway smooth muscle. The dopamine D1 re-
ceptors were detected at the level of mRNA and protein,
and a dopamine D1-like receptor-selective agonist facili-
tated relaxation against acetylcholine-induced contractionin airway smooth muscle through cAMP production and
PKA activation.
In addition to the expression in the central nervous sys-
tem, numerous studies have also demonstrated the expres-
sion of functional dopamine D1 receptors in peripheral
organs and tissues such as the myocardium, pulmonary ar-
tery, renal tubules, gastrointestinal tract, and the zona
glomerulosa cells of the adrenal cortex [4-7,24-27]. Identi-
fication of mRNA in freshly dissected human airway
smooth muscle ensures that native expression of the dopa-
mine D1-like receptor (D1 and D5) is being examined.
Figure 5 Dopamine induced airway smooth muscle relaxation
after an acetylcholine EC50 contraction in intact guinea pig
trachea. Dopamine, in a concentration-dependent manner, relaxes
acetylcholine (Ach)-induced contractions in guinea pig tracheal
rings. (A) Representative tension tracing in guinea pig tracheal ring
illustrating relaxation of Ach (EC50) contraction by dopamine
(1 - 100 μM). (B) The effect of cumulative concentration of
dopamine (1 - 100 μM) on Ach (EC50)-induced guinea pig tracheal
ring contraction. Open circles: dopamine alone. Filled circles: time
control. Means ± SEM. *P < 0.05 and **P < 0.01 compared with time
control. N = 5. Figure 6 Selective dopamine D1 receptor agonist induced
airway smooth muscle relaxation after an acetylcholine EC50
contraction in intact guinea pig trachea. The dopamine D1-like
receptor agonist, A68930, in a concentration-dependent manner, relaxes
Ach-induced contractions in guinea pig tracheal rings. (A) Representative
tension tracing in guinea pig tracheal ring illustrating relaxation of Ach
(EC50) contraction by A68930 (1 - 100 μM) in the presence or absence of
dopamine D2 receptor selective antagonist L-741626 (10 μM). (B) The
effect of cumulative concentration of A68930 (1 - 100 μM) on Ach (EC50)-
induced guinea pig tracheal ring contraction in the presence or absence
of L-741626 (10 μM). Open circles: A68930 alone. Filled circles: L-741626 +
A68930. Filled triangle: time control. Means ± SEM. *P< 0.05, **P< 0.01
and ***P< 0.001 compared with time control. #P< 0.05 compared with
A68930 alone. N = 6.
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careful dissection, freshly isolated tissue could be contami-
nated by other cells types that could give rise to cDNA
products during sensitive RT-PCR amplification. To con-
firm the expression of dopamine D1–like receptor in air-
way smooth muscle itself, we also evaluated its expression
in primary cultured HASM cells which are a homogenous
population of airway smooth muscle cells. In the present
study, there was good agreement between the expression
of dopamine D1-like receptor in freshly isolated native air-
way smooth muscle and from cultured HASM cells. These
findings were in accordance with the previous findings
using expression microarrays in that mRNA of both dopa-
mine D1-like receptor subtypes was expressed in HASMcells [28]. Moreover, in agreement with these mRNA ana-
lyses, the dopamine D1 receptor protein was also identified
in airway smooth muscle from native human airway
Figure 7 PKA is involved in dopamine D1 receptor agonist-
induced airway smooth muscle relaxation. (A) Representative
tension tracing in guinea pig tracheal ring illustrating the effect of
pretreatment with the PKA inhibitor Rp-cAMPS (100 μM) or BKCa channel
blocker iberiotoxin (100 nM) on relaxation of Ach (EC50) contraction by
the dopamine D1-like receptor agonist A68930 (10 - 100 μM). (B) The
effect of pretreatment with the PKA inhibitor Rp-cAMPS (100 μM) or BKCa
channel blocker iberiotoxin (100 nM) on A68930 (100 μM)-mediated
tracheal ring relaxation. Means ± SEM. ***P< 0.001 compared with time
control. ##P< 0.01 compared with A68930 alone. N = 6.
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dependent sources. Immunohistochemical analysis also
confirmed the expression of dopamine D1 receptor on air-
way smooth muscle in both human and guinea pig airwaysmooth muscle. On the other hand, the dopamine D5 re-
ceptor protein was not identified in both human and
guinea pig native airway smooth muscle tissue, and cul-
tured HASM cells by immunoblotting and immunohisto-
chemistry. The discrepancy of the results obtained from
RT-PCR and protein analyses on the expression of dopa-
mine D5 receptor on airway smooth muscle is likely due
to posttranscriptional regulation, differences in mRNA
and protein turnover rates [29,30], or detection of small
amounts of dopamine D5 mRNA by sensitive PCR tech-
niques that does not translate into detectable levels of
dopamine D5 protein. Several studies also described the
correlation between mRNA and protein expression as
moderately or weakly positive with correlation coefficients
ranging from 0.2 to 0.5 [30-33].
Molecular identification of dopamine D1 receptor on
airway smooth muscle itself led us to question whether
functional dopamine D1 receptors could modulate airway
smooth muscle tone. First, we sought to assess its ability
to increase cyclic AMP and relax airway smooth muscle.
Many studies have demonstrated that the activation of Gs-
coupled receptors (e.g., β2-adrenoceptor) stimulates
adenylyl cyclase activity, which leads to cAMP accumula-
tion in airway smooth muscle [15,34,35]. Accumulation of
cAMP content in airway smooth muscle facilitates relax-
ation [15,34,35]. In accordance with the previous findings
on Gs-coupled receptors, our findings demonstrate that
activation of the dopamine D1 receptor expressed on
HASM cells with the endogenous ligand dopamine stimu-
lated cAMP production in HASM cells but only when the
dopamine D2-Gi coupled receptor was inhibited with L-
741626. These findings suggest that dopamine exerts its
effect equally on both dopamine D1-Gs coupled receptor
and dopamine D2-Gi coupled receptor in HASM cells,
and selective stimulation of the dopamine D1 receptor is
required to stimulate cAMP production. Dopamine also
relaxed acetylcholine-contracted guinea pig airway rings,
however, contrary to the dopamine-stimulated cAMP pro-
duction in HASM cells, the relaxation was produced with-
out the blockade of dopamine D2 receptor (data not
shown). These findings would suggest that the dopamine
D2 receptor is more effectively coupled to Gi/adenylyl cy-
clase inhibition in the cultured HASM cells compared to
intact tracheal rings. Another possibility is that in tracheal
rings the dopamine-mediated relaxation is partially medi-
ated through dopamine effects on β2-adrenoceptors. It
was previously reported that dopamine-mediated relax-
ation of acetylcholine-contracted guinea pig trachea was
partially blocked by the β-adrenoceptor antagonist pro-
pranolol [12]. These findings suggest that dopamine in-
duces airway smooth muscle relaxation via both dopamine
D1 receptors and β2-adrenoceptors.
To characterize the dopamine D1 receptor-specific ef-
fects on airway smooth muscle, the selective dopamine
Figure 8 Dopamine D1 receptor-mediated guinea pig airway relaxation is Epac independent. (A) Representative tension tracing in guinea
pig tracheal ring after an acetylcholine contraction followed by increasing concentrations of the dopamine D1-like receptor agonist A68930 (1 -
100 μM) in the presence or absence of the Epac antagonist NSC45576 (250 μM). Top tracing is A68930 alone, and bottom tracing represent treatment
with A68930 after 15 min pretreatment with NSC45576. (B) The effect of pretreatment with NSC45576 (250 μM) on A68930 (1 - 100 μM)-mediated
tracheal ring relaxation. Open circles: A68930 alone. Filled circles: NSC45576 + A68930. Means ± SEM. N = 4. (C) Representative tension tracing in guinea
pig tracheal ring after an acetylcholine contraction followed by increasing concentrations of β-adrenoceptor agonist isoproterenol in the presence or
absence of NSC45576 (250 μM). Top tracing is isoproterenol alone, and bottom tracing represent treatment with isoproterenol after 15 min
pretreatment with NSC45576. (D) Isoproterenol concentration-response curves comparing treatment with isoproterenol alone (open circles) to
isoproterenol after pretreatment with NSC45576 (250 μM) (filled circles). *P < 0.05 compared with isoproterenol alone. N = 5.
Mizuta et al. Respiratory Research 2013, 14:89 Page 11 of 14
http://respiratory-research.com/content/14/1/89D1 receptor agonists A68930 and SKF38393 were used in
the present study. Both agonists stimulated cAMP produc-
tion in HASM cells, and A68930 induced airway smooth
muscle relaxation in guinea pig tracheal rings. The speci-
ficities of A68930 (1 μM) at the dopamine D1 receptor in
the present study were further supported by the finding
that two different dopamine D1-like receptor antagonists
SCH23390 or SCH39166 significantly blocked the effects
of A68930 on cAMP production. However, treatment the
HASM cells with A68930 at a higher concentration
(100 μM) resulted in decrease in cAMP production com-
pared with 1 μM of A68930. A68930 is a potent dopamine
D1 receptor agonist (EC50 = 2.1 nM), but it also stimulates
the Gi-coupled dopamine D2 receptor at higher concentra-
tions (EC50 = 3.92 μM) [22]. We have previously reportedthat the acute activation of the dopamine D2 receptor
expressed in HASM cells inhibited forskolin-stimulated
adenylyl cyclase activity [14], which consequently reduces
in cellular cAMP levels. These findings indicate that
A68930 at higher concentrations may lose its selectivity
against dopamine D1 receptors. This idea was further sup-
ported in the present study by demonstrating that the
dopamine D2 receptor selective antagonist L-741626 sig-
nificantly augmented A68930-induced guinea pig airway
ring relaxation. In the present study, the concentration of
A68930 which was required to produce significant relax-
ation in guinea pig airway ring was higher (≧ 20 μM) than
that required to produce significant cAMP production in
HASM cells (≧ 100 nM). Previous reports in tissue organ
bath also showed that phenylephrine-contracted human
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lium suspended in organ bath was dose-dependently re-
laxed by A68930 (EC50 = 3.5 ± 0.9 μM) [36]. In contrast, in
a cell-based cAMP assay, the EC50 value of A68930-
stimulated cAMP activity in LLC-PK1 cells was much
lower (EC50 = 12.7 ± 2.7 nM) [37]. These results and our
findings suggest that at least 200-fold higher concentration
of A68930 is needed for experiments on tissues where
penetration to their site of action may not be equivalent to
that achieved in a cell monolayer.
Classically, most cAMP effects have been attributed to
the activation of PKA. PKA has multiple intracellular
targets that favor relaxation including phosphorylation
of MLCK which leads to a decrease in its affinity for the
calcium-calmodulin complex [38], resulting in airway
smooth muscle relaxation [15,16]. As expected, the
present study demonstrated that a PKA inhibitor
Rp-cAMPS significantly attenuated dopamine D1 receptor-
mediated airway relaxation. However, several cAMP-
mediated cellular events in airway smooth muscle are
insensitive to PKA inhibition. Spicuzza et al. suggested
that β2-adrenoceptor agonists suppressed acetylcholine-
induced guinea pig airway contraction by mechanisms
that are independent of PKA [39]. Recently, Epac has
been identified as cAMP-regulated guanine nucleotide
exchange factors for Ras-like GTPases, such as Rap1 and
Rap2 [40], and been recognized as an alternative cAMP
sensor to relax smooth muscle in addition to PKA.
Roscioni et al. demonstrated the protein expression of
two isoforms of Epac (Epac 1 and Epac2) in human and
guinea pig trachea, and activation of Epac relaxes airway
smooth muscle by decreasing MLC phosphorylation
[17]. They also claimed that β2-adrenoceptor agonist re-
laxes airway smooth muscle through Epac rather than
PKA [17]. In contrast, in the present study, the Epac se-
lective antagonist NSC45576 did not block dopamine D1
receptor agonist-induced airway relaxation. These results
suggest that although both the dopamine D1 receptor and
β2-adrenoceptor are Gs-coupled receptor, induce airway
smooth muscle relaxation and increase cAMP, that the
subsequent signaling targets of this cAMP elevation may
not be identical following these receptors’ activations.
In addition to these cAMP-dependent mechanisms, a
mechanism independent of cAMP is also relevant in β2-
adrenoceptor-mediated relaxation of airway smooth
muscle [23,41], which involves the opening of the BKCa
channel causing plasma membrane hyperpolarization fa-
cilitating relaxation [41,42]. However, in the present
study, blockade of the BKCa channel with iberiotoxin did
not inhibit relaxation induced by a dopamine D1 recep-
tor agonist.
In the present study, there are several differences in
the results from the cell-based cAMP assays and intact
tissue organ bath studies with the dopamine D1 receptoragonist A68930. The first difference is that the relaxation
evoked by isoproterenol and dopamine was rapid, while
that evoked by A68930 was slow. These results suggest that
the agonists’ interaction with the receptor can affect the
speed of onset and duration of the induced relaxation. Vari-
ations in the molecular structure of agonists can affect the
onset and duration of bronchodilation. For example, iso-
proterenol is a short-acting β agonist and has rapid onset,
while the long-acting β2-adrenoceptor agonist salmeterol
causes sustained relaxation in airway smooth muscle of at
least 12 hrs after a single administration [43], but the speed
of onset is much slower than short-acting agonists such as
isoproterenol [44]. There are remarkable differences in mo-
lecular structure between these agonists and these differ-
ences affect the speed of onset and duration of their effects
[45,46]. These findings suggest that, even though the ago-
nists act on the same receptor, the molecular structure can
affect the kinetics of the drug effect at the receptor. The
second difference between cell-based and tissue-based re-
sults with A68930 in the present study is the time required
to reach significant relaxation in guinea pig airway rings
was longer than the time required for significant stimula-
tion of cAMP production in HASM cells. The dopamine
D1 agonists A68930 and A77636 contain an isochroman
structure and are potent dopamine D1 agonists which exert
long-lasting effects compared with dopamine in vivo. For
example, A68930 elicited prolonged contralateral turning
behavior in 6-hydroxydopamine lesioned rats (>20 hrs)
[47]. In contrast, several reports showed that A68930 stim-
ulated cAMP production within 15 - 20 min [37,48]. How-
ever, it has not been determined whether the long-acting
effects of A68930 rely exclusively on cAMP production.
Thus, it is possible that sustained relaxation of airway
smooth muscle is not solely mediated by increased cAMP
and that other intracellular signaling events may be in-
volved. Further studies will be needed to clarify the intracel-
lular mechanisms by which A68930 induces airway smooth
muscle relaxation.
Conclusion
In summary, our findings demonstrated for the first time
the molecular expression of Gs-coupled dopamine D1 re-
ceptors in human and guinea pig airway smooth muscle
that can stimulate cAMP production in HASM cells and
relax intact airway smooth muscle contracted with
acetylcholine in the PKA-dependent manner. Although
the Gs-coupled β2-adrenoceptor is a critical mediator of
therapeutic relaxation of airway smooth muscle in dis-
eases such as asthma and chronic obstructive pulmonary
disease, less attention has focused on other Gs-coupled
receptors on airway smooth muscle. Our findings sug-
gest that the Gs-coupled dopamine D1 receptor may be a
potential therapeutic target for relaxation of airway
smooth muscle.
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